Highlights of Business Today - 24th May, 2026 edition:

One of the biggest strategic bets in Indian corporate history is the recent Sun Pharmaceutical Industries’ $11.75-billion acquisition of US-based Organon, a move that could transform the company from India’s largest drugmaker into a truly global pharmaceutical powerhouse. Business Today’s latest issue takes a deep dive into Dilip Shanghvi’s high-stakes gamble, examining how the deal expands Sun Pharma’s footprint across more than 140 markets while opening up new opportunities in women’s health, biosimilars, specialty medicines, and China. At the same time, it explores the challenges ahead — from debt and integration risks to the pressure of scaling a multinational healthcare business at a time of major shifts in the global pharmaceutical industry.

Also take a detailed look at GIFT City’s ambitions of becoming India’s global financial gateway, the IPL’s transformation into a serious global investment and sports business powerhouse, and India’s breakthrough in nuclear energy with the Kalpakkam prototype fast breeder reactor reaching criticality — a milestone that could strengthen the country’s long-term energy security ambitions.

All this and more in the latest issue of Business Today Magazine. Out on stands now!